 |
|
 |
 |

Home > Company Index > Drugs > Drug Manufacturers - Other > SIGA Technologies, Inc.
 |
SIGA Technologies, Inc. |
 |
 |
 |
PROFILE |
 |
SIGA Technologies is a development-stage company involved in developing vaccines, novel anti-infectives, and antibiotics for infectious diseases through its Siga Research Labs division. Its lead candidate is a vaccine for strep throat administered directly through the mucus-lined surfaces (mouth, nose, lungs, and gastrointestinal and urogenital tracts) that are the usual entry points for most infectious agents. Development partners include Wyeth-Ayerst (a unit of American Home Products), Chiron, and the Regents of the University of California. SIGA traded its PeerFinder instant messenger technology for a share of Open-i Media, and internet development company, but is now reducing its stake.
COMPETITION |
 |
Antex Biologics Inc. (ANX)
Corixa Corporation (CRXA)
Cubist Pharmaceuticals, Inc. (CBST)
DEALS |
 |
Deal: Siga Acquires Hypernix
Date Announced: 06.01.00
Value of transaction (US $Mil): 12.5
Description: Communications software firm acquires Israel-based messaging software company for 3 million shares of stock; assumes $1.25 million in liabilities.
> Search all deals for this company
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 0.50
1-Yr. Sales Growth: 0.0%
Employees: 17
Revenue per employee: $29,411.76
KEY PEOPLE |
 |
Philip N. Sussman
CEO
Thomas N. Konatich
CFO
CONTACT INFO |
 |
420 Lexington Ave., Ste. 620
New York, NY 10170
US
Phone: 212-672-9100
Fax: 212-697-3130
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |